ruxolitinib,hydroxyurea
ayala pharmaceuticals,incyte,novartis,rafael pharma
['ruxolitinib', 'myeloid', 'leukemia', 'rux,(-crux),(-trux),(-deruxtecan)', 'hydroxyurea', 'ayala', 'rafael ']
findings suggest that ruxolitinib could reduce the incidence of arterial thrombosis, but a disease-modifying effect could not be demonstarted for ruxolitinib in this patient population #ash22 
An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)